Screener
Bristol-Myers Squibb BMY Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's other non-current liabilities?
- Bristol-Myers Squibb (BMY) reported other non-current liabilities of $4.34B in Q2 2026.
- How has Bristol-Myers Squibb's other non-current liabilities changed year-over-year?
- Bristol-Myers Squibb's other non-current liabilities decreased by 12.2% year-over-year, from $4.94B to $4.34B.
- What is the long-term trend for Bristol-Myers Squibb's other non-current liabilities?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's other non-current liabilities has grown at a -8.3% compound annual growth rate (CAGR), from $7.78B to $5.04B.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Bristol-Myers Squibb's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude